RxDoctor Payments Data

Derek Johnson, PA

Physician Assistant · Boca Raton, FLNPI 1962746172

Payments from drug & device makers

$1,813in general payments, 2019–2025

Across 71 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$393
  • Urogen Pharma, Inc.$348
  • Sumitomo Pharma America, Inc.$177
  • Johnson & Johnson$149
  • Ferring Pharmaceuticals Inc.$146
  • Blue Earth Diagnostics$116
  • plus $484 from 15 others

What the payments were for

  • Food & beverage$1,74596%
  • Education$684%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,813 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$116,000
Medicare patients
389
Services billed
13,902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron130$101,627
GemtesaVibegron133$90,760
Tamsulosin Hcl611$12,835
Methenamine Hippurate132$10,363
Mirabegron ErMirabegron17$7,910
Finasteride228$4,333
Solifenacin Succinate83$2,738
Alfuzosin Hcl ErAlfuzosin Hcl105$2,728
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst82$1,808
CefuroximeCefuroxime Axetil152$1,584
Dutasteride27$945
Trimethoprim12$527
Bicalutamide21$522
Oxybutynin Chloride ErOxybutynin Chloride19$354
Ciprofloxacin Hcl70$296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$58$101,627130 claims
Sumitomo Pharma America, Inc.Gemtesa$177$90,760133 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →